Tandem Autologous Stem Cell Transplantation Improves Outcomes in Newly Diagnosed Multiple Myeloma with Extramedullary Disease and High-Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Clicks: 438
ID: 114940
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #5 of 15 articles by views in biology of blood and marrow transplantation : journal of the american society for blood and marrow transplantation

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Although high-dose therapy and autologous stem cell transplant combined with novel agents continues to be the hallmark of first-line treatment in newly diagnosed transplant-eligible multiple myeloma patients, the impact of tandem autologous or autologous/reduced-intensity allogeneic transplant for p …
Reference Key
n2019biologytandem Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Gagelmann N;Eikema DJ;Koster L;Caillot D;Pioltelli P;Lleonart JB;Reményi P;Blaise D;Schaap N;Trneny M;Passweg J;Porras RP;Cahn JY;Musso M;Poiré X;Fenk R;Itälä-Remes M;Pavone V;Fouillard L;Maertens J;Bron D;Pouli A;Schroyens W;Schönland S;Garderet L;Yakoub-Agha I;Kröger N;;
Journal biology of blood and marrow transplantation : journal of the american society for blood and marrow transplantation
Year 2019
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.